- Investigator
- Arshag Mooradian
- Status
- Accepting Candidates
- Ages
- 75 Years - 100 Years
- Sexes
- All
Treats Adults
Arshag Mooradian, MD
Endocrinologist
Research at a glance
Top areas of exploration
- Aging , 71 publications
- RNA, Messenger , 45 publications
- Apolipoprotein A-I , 41 publications
- Diabetes Mellitus , 39 publications
Research activity
Active clinical trials
My publications
Filter publications
329 publications
2014
Inhibition of apolipoprotein A-I expression by TNF-alpha in HepG2 cells: requirement for c-jun.
Journal of cellular biochemistry
鈥�2014
Urinary 3,3'-diindolylmethane: a biomarker of glucobrassicin exposure and indole-3-carbinol uptake in humans.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
鈥�2013
Redesigning medical education to improve health care delivery and outcomes.
The health care manager
鈥�2013
Dyslipidemia in type 2 diabetes: prevalence, pathophysiology, and management.
Drugs
鈥�2013
Induction of apolipoprotein A-I gene expression by glucagon-like peptide-1 and exendin-4 in hepatocytes but not intestinal cells.
Metabolism: clinical and experimental
鈥�